Skip to content

13F-HR filed by Casdin Capital, LLC

Casdin Capital, LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 32 holding rows worth $1,199,325,239.

Accession
0000919574-25-007006
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 32 entries on the cover page, a total value of $1,199,325,239 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,199,325,239 with VALUE read as dollars as filed, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GENEDX HOLDINGS CORP81663L200COM CL A3,007,164$323,991,849dollars as filed
BIOLIFE SOLUTIONS INC COM NEW09062W204Stock6,707,165$171,099,779dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock2,647,333$123,630,451dollars as filed
STANDARD BIOTOOLS INC34385P108COM77,558,856$100,826,513dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock1,780,000$77,554,600dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock11,341,381$59,202,009dollars as filed
ILLUMINA INC452327109COM525,000$49,859,250dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY1,555,000$43,540,000dollars as filed
BEAM THERAPEUTICS INC07373V105COM1,600,000$38,832,000dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock55,000$25,080,000dollars as filed
TEMPUS AI INC CL A88023B103Stock294,127$23,738,990dollars as filed
NEUROGENE INC64135M105COMMON STOCK1,295,361$22,448,606dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock758,857$19,677,162dollars as filed
PRIME MEDICINE INC74168J101COM3,167,175$17,546,150dollars as filed
ARS PHARMACEUTICALS INC82835W108COM1,600,000$16,080,000dollars as filed
HIMS & HERS HEALTH INC433000106COM CL A230,000$13,045,600dollars as filed
DENALI THERAPEUTICS INC COM24823R105Stock890,000$12,922,800dollars as filed
SEPTERNA INC COM81734D104Stock553,268$10,406,971dollars as filed
VERACYTE INC COM92337F107Stock276,308$9,485,654dollars as filed
UnitedHealth Group Inc91324P102COM25,000$8,632,500dollars as filed
INCYTE CORP COM45337C102Stock100,000$8,481,000dollars as filed
GUARDANT HEALTH INC COM40131M109Stock100,000$6,248,000dollars as filed
EXACT SCIENCES CORP COM30063P105Stock90,000$4,923,900dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW282,312$3,269,173dollars as filed
ABSCI CORPORATION00091E109COM973,260$2,958,710dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock148,333$1,742,913dollars as filed
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock723,767$926,422dollars as filed
RECURSION PHARMACEUTICALS IN75629V104CL A165,323$806,776dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM86,014$637,364dollars as filed
CENTURY THERAPEUTICS INC15673T100COM1,228,190$611,639dollars as filed
TENAYA THERAPEUTICS INC87990A106COM361,969$586,390dollars as filed
GINKGO BIOWORKS HOLDINGS INC37611X209COMMON STOCK36,493$532,068dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-25-007006this filing2025-11-14acceptance time not in the bulk data set